Inhibition of Tumor Microenvironment Cytokine Signaling Sensitizes Ovarian Cancer Cells to Antiestrogen Therapy
- Journal: Cancers (Basel), September 2022
- Authors: Tan L, Tondo-Steele K, Foster C, McIlwain C, Bolland DE, Crawford HC, Sciallis A, McLean K.
- Citation: Cancers (Basel). 2022 Sep 26;14(19):4675. doi: 10.3390/cancers14194675.
- Phung MT, et al. A framework for assessing interactions for risk stratification models: the example of ovarian cancer. J Natl Cancer Inst. 2023 Jul 12:djad137. doi: 10.1093/jnci/djad137. Epub ahead of print. PMID: 37436712.
- de Bear O, et al. Acquired factor VIII inhibitor caused by solid tumor malignancy. Gynecol Oncol Rep. 2023 Jun 7;48:101217. doi: 10.1016/j.gore.2023.101217. PMID: 37576357; PMCID: PMC10422097.
- Phung MT, et al. A comparative study on behavior, awareness and belief about cervical cancer among rural and urban women in Vietnam. PLOS Glob Public Health. 2023 Jun 6;3(6):e0001817. doi: 10.1371/journal.pgph.0001817. PMID: 37279208; PMCID: PMC10243615.
- Maturen KE, et al. Pelvic Recovery After Endometrial Cancer Treatment: Patient-Reported Outcomes and MRI Findings. Acad Radiol. 2023 Apr 24:S1076-6332(23)00168-X. doi: 10.1016/j.acra.2023.03.031. Epub ahead of print. PMID: 37100674.
- Phung MT, et al. Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery. Gynecol Oncol. 2023 Jan;168:68-75. doi: 10.1016/j.ygyno.2022.10.018. Epub 2022 Nov 17. PMID: 36401943; PMCID: PMC10398872.
- Armstrong DK, et al. NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022. J Natl Compr Canc Netw. 2022 Sep;20(9):972-980. doi: 10.6004/jnccn.2022.0047. PubMed PMID: 36075393.
- Coffman LG, et al. Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer. JCI Insight. 2022 Sep 22;7(18):e160573. doi: 10.1172/jci.insight.160573. PMID: 35972817; PMCID: PMC9675476.
- Brieger KK, et al. High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival. Cancer Epidemiol Biomarkers Prev. 2022 Feb;31(2):443-452. doi: 10.1158/1055-9965.EPI-21-0977. Epub 2021 Nov 17. PMID: 34789471; PMCID: PMC9281656.
- Khoja L, et al. Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association. Gynecol Oncol. 2022 Jan;164(1):195-201. doi: 10.1016/j.ygyno.2021.10.088. Epub 2021 Nov 12. PMID: 34776242; PMCID: PMC9444325.
Contact the McLean Laboratory
Department of Gynecology
Department of Pharmacology & Therapeutics
Roswell Park Comprehensive Cancer Center
Elm and Carlton Streets
Buffalo, NY 14263